Combination of thrombophilia markers in acute myocardial infarction of the young.

Indian J Med Sci

Institute of Immunohaematology (I.C.M.R.), 13th Floor New Building, KEM Hospital, Parel, Mumbai-400 012, India.

Published: September 2004

Background: The pathogenesis of arterial thrombotic disease involves multiple genetic and environmental factors related to atherosclerosis and thrombosis. But, there have been very few studies in India which have investigated some of the thrombophilia markers.

Aim: To look for combined thrombophilia in MI patients.

Settings And Design: One hundred twenty patients of myocardial infarction (age below 40 yrs.) were recruited 8-10 weeks after stabilization. Hundred age and sex-matched healthy controls were also recruited in the present study.

Methods And Material: Following thrombophilia markers were screened in these patients--plasma fibrinogen, protein C, protein S, antithrombin III, factor V Leiden, PT G20210A polymorphism, MTHFR C677T, homocysteine, fibrinogen b448 Arg/Lys polymorphism and CBS T833C mutation.

Statistical Analysis: Statistical analysis was done using Statistical Package for Social Sciences (SPSS) version 10.0, SPSS Inc., Chicago, USA.

Results And Conclusion: Elevated fibrinogen levels, homocysteine (p< 0.001 and homocysteine with odds ratio 6.26) and factor V Leiden (p=0.038) were independently associated with MI in our patients. A total of 37 patients (42.5%) had the presence of more than one thrombophilia markers in combination. Out of these, 10 had the presence of three markers in combination and 1 had five thrombophilia markers in combination. Only 2 controls had prothrombotic markers in combination. Combined prothrombotic risk factors were significant in cases in comparison to controls (p< 0.001). Further larger studies on a nationwide basis recruiting a large number of young MI patients should be done to substantiate these findings.

Download full-text PDF

Source

Publication Analysis

Top Keywords

thrombophilia markers
16
markers combination
16
combination thrombophilia
8
myocardial infarction
8
factor leiden
8
analysis statistical
8
markers
6
combination
5
thrombophilia
5
markers acute
4

Similar Publications

Splanchnic vein thrombosis (SVT), which is particularly prevalent in myeloproliferative neoplasms (MPNs), has a multifactorial pathomechanism involving the anticoagulant protein C (PC) pathway. To better characterize the hypercoagulable state in SVT we assessed its key enzymes thrombin and activated PC (APC). The study population included 73 patients with SVT, thereof 36 MPN+, confirmed by bone marrow biopsy, 37 MPN-, and 30 healthy controls.

View Article and Find Full Text PDF
Article Synopsis
  • This study identified a subgroup of acute myeloid leukemia (AML) patients with an APL-like immunophenotype characterized by the absence of CD34 and HLA-DR, aiming to explore differences in clinical and molecular features between them and regular AML patients.
  • Out of 191 patients analyzed, 32 exhibited this specific immunophenotype and were found to have a higher risk of developing disseminated intravascular coagulation (DIC) and showed distinct molecular characteristics, including more frequent NPM1 mutations and higher WT1 gene expression.
  • Despite being in a favorable risk category based on some parameters, patients with the CD34HLA-DR immunophenotype experienced shorter overall survival, underscoring the need
View Article and Find Full Text PDF

This report describes the development of recurrent cutaneous microthrombosis in a patient with the superposition of Factor V Leiden heterozygosity on a noncriteria IgM antibody to phosphatidylserine/prothrombin complex. The patient was treated with prednisone, apixaban, and rituximab and was stable off of prednisone at her last outpatient visit 22 months after the initial event. This report illustrates the challenges of dealing with multifactor thrombophilia especially when one of those factors is a noncriteria antiphospholipid antibody and reaffirms the value of testing for noncriteria antibodies when clinical findings suggest the presence of antiphospholipid antibodies but the criteria antibodies are negative.

View Article and Find Full Text PDF
Article Synopsis
  • This study explored how traditional Chinese medicine (TCM) affects readmission rates and lab results in patients with rheumatoid arthritis (RA) who have a hypercoagulable state.
  • Using a retrospective analysis of patients from a specific hospital, the researchers balanced groups through propensity score matching and assessed the impact of TCM treatment lasting at least one month.
  • Results indicated that RA patients in the hypercoagulable group had higher readmission rates and all-cause mortality, while those treated with TCM showed significantly better outcomes, particularly in terms of readmission and surgical treatment needs.
View Article and Find Full Text PDF

We carried out a retrospective observational investigation to explore the association of endotheliopathy with coagulofibrinolytic reactions and the progression of disseminated intravascular coagulation (DIC) in adult trauma patients. We measured syndecan-1 (SDC-1), an indicator of endotheliopathy, and biomarkers of coagulofibrinolysis in 100 trauma patients immediately transferred to Ehime University Hospital. We evaluated the correlations between the coagulofibrinolytic parameters and SDC-1.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!